Avon takes the lead in Glaxo class action

By 2007-10-10T15:30:00

[16:30 CEST 10-10] UK – Avon Pension Fund has been accepted as the lead plaintiff in a US securities class action suit against pharmaceutical giant GlaxoSmithKline.

You have now reached your article limit

Already a registered user or member? Sign in here

To continue reading, register free today for access

Register Now

Registration also includes access to

IPE Real Assets

Gated access promo

Five reasons to register today

  1. Access to IPE articles from our award-winning editorial team
  2. Unique IPE market data, rankings and tables
  3. In-depth interviews with pension fund leaders
  4. Extensive coverage of latest asset class trends
  5. Comprehensive archive of data, research and intelligence